Immutep Shares Jump 13% on Lung-Cancer Combination Trial Data
By Stuart Condie SYDNEY--Immutep shares are on course for their best day since June after the Australia-listed developer of cancer treatments presented...
Source: marketwatch.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Imm Au. Real-time updates on events, politics, business and more.